Lv1
10 积分 2024-07-22 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
9小时前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
14小时前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1天前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
6天前
已完结
T-cell engagers in rheumatology
6天前
已关闭
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
1个月前
已关闭
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
1个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
1个月前
已完结
In vivo CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
4个月前
已完结
皖公网安备34019202002308
